Series B Round

Clinomic is a dynamic, fast-growing medical technology company focused on developing innovative technological solutions for critically ill patients. The company combines translational medical research, data science, and computational intelligence to create groundbreaking products that support the treatment of critically ill patients and ensure guideline-compliant care. Their flagship product, Mona, leverages AI to enhance decision-making in intensive care units, ultimately improving patient outcomes. Clinomic aims to revolutionize critical care by providing healthcare professionals with advanced tools that facilitate real-time data analysis and patient monitoring. This funding will enable Clinomic to further develop its AI-driven solutions and expand its market presence, enhancing their capabilities in critical care environments.